Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients

Violette Allouchery (1) , Ludivine Beaussire (2) , Anne Perdrix (2, 1) , David Sefrioui (2) , Laetitia Augusto (1) , Cécile Guillemet (3, 1) , Nasrin Sarafan-Vasseur (2) , Frédéric Di Fiore (4, 1, 2) , Florian Clatot (2, 1)

1 CLCC Henri Becquerel - Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen
2 GPMCND - Génomique et Médecine Personnalisée du Cancer et des Maladies Neuropsychiatriques
3 Service d'Oncologie Médicale
4 Département d'oncologie médicale [Rouen]

Domains: Life Sciences [q-bio]; Cancer

Violette Allouchery, Ludivine Beaussire, Anne Perdrix, David Sefrioui, Laetitia Augusto, et al.. Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients. Breast Cancer Research, 2018, 20 (1), ⟨10.1186/s13058-018-0968-0⟩. ⟨hal-02352867⟩